Toxic effects of cadmium on the garden snail (Helix aspersa).

PubWeight™: 0.78‹?›

🔗 View Article (PMID 7260433)

Published in Bull Environ Contam Toxicol on May 01, 1981

Authors

L K Russell, J I DeHaven, R P Botts

Articles by these authors

Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol (1994) 1.02

Comparison of epidemiologic studies in animal and human populations. Can J Public Health (1966) 0.98

Mortality of Missouri veterinarians. J Am Vet Med Assoc (1966) 0.92

Isolation and properties of OSCP and an F1-ATPase binding protein from rat liver mitochondria - evidence against OSCP as the linking "stalk" between F1 and the membrane. Biochem Biophys Res Commun (1976) 0.85

Drug therapy of bacillus Calmette-Guérin sepsis. Urol Res (1995) 0.83

Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer. Urology (1999) 0.80

Early syphilis in an active duty military population and the surrounding civilian community, 1985-1993. Mil Med (1998) 0.80

Keyhole limpet hemocyanin immunotherapy of murine bladder cancer. Urol Res (1993) 0.80

Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer. J Urol (1991) 0.79

A randomized prospective comparison of oral versus intravesical and percutaneous bacillus Calmette-Guerin for superficial bladder cancer. J Urol (1990) 0.78

Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressor (PITS). II. Resolution of multiple PITS beta factors. Cell Immunol (1984) 0.78

Immunotherapy of murine bladder cancer by irradiated tumor vaccine. J Urol (1991) 0.77

Treatment of murine transitional cell carcinoma with intralesional interleukin 2 and murine interferon gamma. J Urol (1991) 0.76

Immunotherapy of murine bladder cancer with keyhole limpet hemocyanin (KLH). J Urol (1993) 0.76

Immunotherapy of murine transitional cell carcinoma of the bladder using alpha and gamma interferon in combination with other forms of immunotherapy. J Urol (1992) 0.75

Anomalous Origin of the Coronary Arteries in Two Calves. Can J Comp Med Vet Sci (1964) 0.75

Clinical effects of repeated cardiac punctures in dogs. J Am Vet Med Assoc (1972) 0.75

A mobility study of Missouri veterinarians. J Am Vet Med Assoc (1965) 0.75

Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressors (PITS)--III. Production of PITS beta factors from T-cell hybridomas. Int J Immunopharmacol (1985) 0.75

The training of auxilliary nurse-midwives in Afghanistan. J Nurse Midwifery (1982) 0.75

Clinical evaluation of methods of treatment. Can J Comp Med Vet Sci (1967) 0.75

Allium sativum (garlic) treatment for murine transitional cell carcinoma. Cancer (1997) 0.75

IL-2/LAK cell treatment for advanced cancers with emphasis on a novel administration. W V Med J (1991) 0.75

Percutaneous, oral, or intravesical BCG administration: what is the optimal route? Prog Clin Biol Res (1989) 0.75

Sexual counseling; an approach to the integration of sexual counseling into the antepartal management of teenagers. J Nurse Midwifery (1975) 0.75